Search Results for 'off-label'
-
How Can Off-Label Use Be Promoted?—Mike on Medtech
Mike Drues and Sean Fenske look at the promotion of off-label use for a medical device and the ways in which it can be done successfully.Sean Fenske, Editor-in-Chief 11.15.22
-
Cardiovascular | Patient Monitoring
FDA OKs AliveCor's KardiaMobile 6L to Measure QTc in COVID-19 Patients
Monitors QT duration in patients receiving medications that can cause potentially life-threatening QT prolongation.PR Newswire 03.24.20
-
R&D & Design
Four Considerations for Developers of Next-Generation Combination Products
Bringing together real-time monitoring, telemedicine, AI, interventions, and pharmaceuticals into a single device produces a number of potential pitfalls.Mark Goodman and Barry Thompson, Baker & McKenzie LLP 03.04.20
-
MPO Summit 2019 Conference Program Notebook
An ongoing update of MPO Summit 2019 sessions.Online Exclusives Michael Barbella, Managing Editor 10.03.19
-
Contract Manufacturing | Electronics | Neurological
Shock to the System: An Examination of Neurostim Technologies
Targeted electrical nerve stimulation technology can aid in chronic disease management by improving on current treatment methods.Sam Brusco, Associate Editor 09.09.19
-
Cardiovascular
JenaValve Technology Implants Initial Patients With Next-Generation TAVR System
Enrollment yields successful implantation with Everdur Transcatheter Valve.Business Wire 08.01.18
-
Cardiovascular | Diagnostics | Digital Health | Neurological | Patient Monitoring | Surgical
Off-Label Use—Mike on Medtech
Mike Drues and Sean Fenske discuss the off-label use of medical devices and the promotion of such use.Sean Fenske, Editor-in-Chief 08.25.17
-
-
Midyear Medtech Review
...Mark Bonifacio, Founder and President, Bonifacio Consulting Services 06.06.17
-
Cardiovascular | Diagnostics | Digital Health | Neurological | Patient Monitoring | Surgical | Testing
-
Testing
Researchers Propose Changes to FDA's Regulation of Off-Label Medical Device Use
Trio urges FDA to expand its current post-market testing requirements.01.28.15
-
R&D & Design
FDA: King Systems Promoted Oropharyngeal Airway for Off-Label Use
Indiana-based firm has 15 days to respond to agency.Editor 12.02.09
-
R&D & Design
FDA: King Systems Promoted Oropharyngeal Airway for Off-Label Use
Indiana-based firm has 15 days to respond to agency.Editor 12.02.09
-
Two Synthes Execs Plead Guilty To Off-Label Bone-Mending Cement Trials
Could face jail time and $100,000 fine.Editor 08.03.09
-
Two Synthes Execs Plead Guilty To Off-Label Bone-Mending Cement Trials
Could face jail time and $100,000 fine.Editor 08.03.09
-
FDA Issues Warning Letter for Off-Label Promotion of Orthopedic Implant
The orthopedic implant company received CE Mark approval in 2008.Editor 03.16.09
-
FDA Issues Warning Letter for Off-Label Promotion of Orthopedic Implant
The orthopedic implant company received CE Mark approval in 2008.Editor 03.16.09
